SNDX

Syndax Pharmaceuticals Inc

• Simply Wall St·5d ago

  Syndax Pharmaceuticals (SNDX) Looks Undervalued On Paper, Is It Still A Bargain?

• TipRanks·6d ago

  Analysts Offer Insights on Healthcare Companies: Syndax Pharmaceuticals (SNDX) and Pyxis Oncology (PYXS)

• TipRanks·09/29 10:25

  Axatilimab’s Emerging IPF and cGVHD Profile Supports Buy Rating on SNDX, With Price Target Unchanged at $57

• Seeking Alpha·09/28 09:22

  Syndax: 'Strong Buy' Revuforj Pipeline Growth And Niktimvo Q4 2026 Data Releases

• Seeking Alpha·09/25 16:28

  Syndax Pharmaceuticals: Buy The Pullback Ahead Of Q4 Readouts

• Simply Wall St·09/23 09:28

  Syndax Pharmaceuticals (SNDX) Stock Looks Fully Valued After Its 21% Gain

• TipRanks·09/22 09:25

  H.C. Wainwright Sticks to Its Buy Rating for Syndax Pharmaceuticals (SNDX)

• Simply Wall St·09/11 10:26

  Syndax Pharmaceuticals (SNDX) Stock May Be Pricey Following A 15% Gain

• Simply Wall St·08/25 09:23

  Syndax Pharmaceuticals (SNDX), Why Is It Drawing Fresh Attention?

• TipRanks·08/22 10:05

  Citi Predicts Up to 410% Rally for These 2 ‘Strong Buy’ Stocks

• Dow Jones·08/21 15:54

  Syndax Pharmaceuticals Price Target Cut to $33.00/Share From $37.00 by UBS

• Dow Jones·08/21 15:54

  Syndax Pharmaceuticals Is Maintained at Buy by UBS

• Benzinga·08/21 15:44

  UBS Maintains Buy on Syndax Pharmaceuticals, Lowers Price Target to $33

• TipRanks·08/21 11:15

  Syndax price target lowered to $33 from $37 at UBS

• Simply Wall St·08/17 14:20

  Loss of China Rights for Jing Zhu Da Might Change The Case For Investing In Syndax (SNDX)